Tag Archives: European Union approval

Sanofi’s Sarclisa Becomes First Anti-CD38 Therapy Approved in the EU for Front-Line Treatment of Transplant-Ineligible Multiple Myeloma

(IN BRIEF) Sanofi’s Sarclisa has been approved by the European Union as the first anti-CD38 therapy in combination with VRd to treat adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. This approval is … Read the full press release